Alternative investment funds managed by European regulated asset managers
The data shown is taken from a database provided by european regulators. Date of update: 2025-04-10
Fund type available: AIF, ELTIF, EuSEF and EuVECA.
Click on the Fund’s LEI for more information or Use our search module for additional data.
| Fund Manager Name | Fund Name | Fund Type | Fund Manager State | Fund Manager LEI | Fund LEI |
|---|---|---|---|---|---|
| IFM Independent Fund Management AG | Global Microfinance and SME Debt Fund | AIF | LIECHTENSTEIN | 529900R8C5JSAWC1EW32 | 529900GGRP3MLCVJYV75 |
| LGT Fund Management Company Ltd. | Kids Generation Fund | AIF | LIECHTENSTEIN | 549300T5WUIAB7GDLC73 | 529900RFH7DBP6J9PA85 |
| LGT Capital Partners (FL) AG | LGT CP Portfolio Management SICAV | AIF | LIECHTENSTEIN | Z1C2CNQL65L8VZ278H86 | 391200ATADZM5IBSMK90 |
| IFM Independent Fund Management AG | Beaver Fund - North America | AIF | LIECHTENSTEIN | 529900R8C5JSAWC1EW32 | 529900GLXZFWJKKLRL12 |
| VP Fund Solutions (Liechtenstein) AG | Seed X Funds SICAV - VC Fintech II | AIF | LIECHTENSTEIN | 529900R5UQB9UVVBIM04 | 529900G2QBRPSZOMTN05 |
| ONE Funds AG | Halcon Investment SICAV - Halcon Innovation Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 8755001RYZ4WC4Y4S538 |
| LGT Fund Management Company Ltd. | Draco Fund - Draco Global Credit Opportunities Fund | AIF | LIECHTENSTEIN | 549300T5WUIAB7GDLC73 | 529900FMWYS4EBDUSF67 |
| 1741 Fund Management AG | HESTIAS SA, SICAV-FIAR-HESTIAS – ENDOWMENT MODEL II | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900TFKJEG94J33O20 |
| Accuro Fund Solutions AG | C&S Synergy Fund SICAV - SG CEE Fund | AIF | LIECHTENSTEIN | 529900UJ5383SU2X7B49 | 529900ZEJJIRDOL6L593 |
| VP Fund Solutions (Liechtenstein) AG | RICHTWERT Funds - RICHTWERT Global Opportunities Fund | AIF | LIECHTENSTEIN | 529900R5UQB9UVVBIM04 | |
| ONE Funds AG | Halcon Investment SICAV - Antarctic Investment Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 875500AN60GI8D09B371 |
| ONE Funds AG | Halcon Investment SICAV - Arami Capital Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 875500QND8VK6Q5RNL64 |
| ONE Funds AG | Halcon Investment SICAV - Gingolph Capital Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 875500SHVDJAS2L1U567 |
| 1741 Fund Management AG | HESTIAS SA, SICAV-FIAR-HESTIAS – ENDOWMENT MODEL I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900TFKJEG94J33O20 |
| IFM Independent Fund Management AG | European Entrepreneurs Funds SICAV | AIF | LIECHTENSTEIN | 529900R8C5JSAWC1EW32 | 529900AXW1ATMOAT4I98 |
| 1741 Fund Management AG | Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I | AIF | LIECHTENSTEIN | 549300EBXJ983V6UNV73 | 529900LOP5GC7BXUB474 |
| CAIAC Fund Management AG | Wyden Systematic Momentum Fund | AIF | LIECHTENSTEIN | 529900PY3KLUDU87D755 | 875500OK32C5448TOQ61 |
| Ahead Wealth Solutions AG | SKP Investments SICAV | AIF | LIECHTENSTEIN | 5299008WBM29C45SRF98 | 529900EBZ44X6IKEYH37 |
| Accuro Fund Solutions AG | AFS Alternative Fund SICAV - Artis Trade Invest Fund | AIF | LIECHTENSTEIN | 529900UJ5383SU2X7B49 | 529900L45BKBAHE9BP39 |
| IFM Independent Fund Management AG | Innformance Funds - PE Capital VIII | AIF | LIECHTENSTEIN | 529900R8C5JSAWC1EW32 | 529900RUWYEFCR9KEC12 |
| IFM Independent Fund Management AG | Kaleido Funds - Kaleido Digital Asset Core Fund | AIF | LIECHTENSTEIN | 529900R8C5JSAWC1EW32 | 529900RFFL7AITG1U482 |
| ONE Funds AG | KYRI SICAV - KYRI Opportunities I Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 529900I4W3TNEF2VYC52 |
| VP Fund Solutions (Liechtenstein) AG | Capeo Umbrella Funds - Capeo Pentagon Credit Select Fund | AIF | LIECHTENSTEIN | 529900R5UQB9UVVBIM04 | |
| ONE Funds AG | Halcon Investment SICAV - XTech Investment Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 8755007L3QIVZ5DES957 |
| ONE Funds AG | SIAG Investment Fund | AIF | LIECHTENSTEIN | 529900J0DPRJZBLJIA32 | 529900S89DF7N027SE88 |
Warning: The AIF funds listed here are reserved for professional or institutional investors. These products are not authorised for sale to the general public. Subscription by private individuals is prohibited, unless otherwise provided for by the regulations.